Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5
Status:
Completed
Trial end date:
2018-12-14
Target enrollment:
Participant gender:
Summary
The objective of the study is to demonstrate the superiority of 0.1% octenidine mouthwash
(Octenidin Mundspüllösung, OML) to placebo (PLAC) in the inhibition of plaque formation. The
study will consist of a 14-day screening period and a 5-day treatment period.